A Trial of Cervidil for Outpatient Pre-induction of Cervical Ripening
Status:
Terminated
Trial end date:
2020-04-11
Target enrollment:
Participant gender:
Summary
Induction of labor is a frequently planned obstetric procedure. Induction for women with an
unfavorable cervix (bishop score <6) increases the risk of cesarean section. This risk may be
reduced by ripening or softening the cervix before the induction of labor. This protocol
outlines a randomized trial of 200 women evaluating the placement and use of Cervidil to the
post vaginal fornix to soften the cervix in preparation for induction.
This trial is looking at inpatient vs outpatient pre-induction cervical ripening using
Cervidil and the effects on (1) maternal and newborn outcomes including time of admission to
delivery, (2) system healthcare cost, (3) cost to patient, and (4) patient satisfaction.
The investigators hypothesize when compared to patients admitted to the hospital for cervical
ripening:
1. From the time of admission, patients in the outpatient cervical ripening arm will
progress to complete cervical dilation in less time.
2. The total overall cost of care for the encounter will be reduced for the group in the
outpatient cervical ripening arm.
3. Patients in the outpatient cervical ripening arm will have more overall satisfaction.